This study aims to provide an integrative overview of the roles of zinc, magnesium and vitamin B6 in the pathophysiology of type 2 diabetes, with a particular focus on their interaction with the gut microbiota. It seeks to synthesize current evidence on how these micronutrients influence glucose metabolism, insulin signaling and inflammatory processes, while also examining the bidirectional relationship between micronutrient status and microbial composition. Ultimately, the article intends to highlight emerging mechanisms and identify potential nutritional and microbiota-targeted strategies for improving the prevention and management of type 2 diabetes.
This study adopts a narrative review methodology, integrating evidence from nutritional, metabolic and microbiological research. A comprehensive literature search was conducted using major scientific databases to identify relevant studies examining the roles of zinc, magnesium and vitamin B6 in type 2 diabetes, as well as their interactions with the gut microbiota. Both experimental and clinical studies, including observational research, randomized trials and systematic reviews, were considered. The selected literature was critically analyzed and synthesized to provide a cohesive understanding of the complex, bidirectional relationships between micronutrient status, microbial composition and metabolic regulation in type 2 diabetes.
The findings indicate that zinc, magnesium and vitamin B6 play critical and interconnected roles in glucose metabolism, insulin signaling and inflammation in type 2 diabetes. Deficiencies in these micronutrients are consistently associated with impaired glycemic control and increased risk of complications. In addition, substantial evidence highlights a bidirectional relationship between micronutrient status and gut microbiota composition, where dysbiosis contributes to metabolic dysfunction while also influencing micronutrient availability. The review further reveals that targeting these interactions through dietary strategies, supplementation and microbiota modulation may offer complementary approaches to improve metabolic outcomes in individuals with type 2 diabetes.
This review has several limitations. As a narrative review, it is subject to potential selection bias and does not provide a quantitative synthesis of the available evidence. In addition, much of the current knowledge regarding micronutrient–microbiota interactions derives from observational studies and animal models, limiting the ability to establish causality in humans. Despite these limitations, the review highlights the potential clinical relevance of zinc, magnesium, vitamin B6 and gut microbiota in T2D management. The findings support the need for personalized nutritional approaches and provide a framework for future clinical and translational research in this emerging field.
Micronutrient assessment may be particularly valuable in patients with long-standing T2D, diabetic neuropathy or nephropathy, obesity, poor glycaemic control or chronic metformin use, as these groups may be at increased risk of nutritional deficiencies. Practical dietary strategies include increasing the consumption of legumes, whole grains, nuts, seeds, fish, lean meats and green leafy vegetables, which are rich sources of zinc, magnesium and vitamin B6 and can be readily incorporated into a balanced T2D diet. However, supplementation should be individualized and monitored, as excessive zinc intake may disrupt gut microbiota composition, impair copper absorption and alter mineral homeostasis.
Given the growing global burden of type 2 diabetes, strategies that promote adequate micronutrient intake and support a healthy gut microbiota may have important public health implications. Encouraging the consumption of nutrient-dense foods such as legumes, whole grains, nuts, seeds, fish, fruits and vegetables may contribute to improved metabolic health while supporting broader dietary quality. These approaches are generally accessible, cost-effective and compatible with existing diabetes prevention programs. Furthermore, increasing awareness among healthcare professionals and the public about the role of nutrition and gut health may help reduce diabetes-related complications and associated healthcare costs.
This review provides a novel and integrative perspective by simultaneously examining the roles of zinc, magnesium and vitamin B6 alongside gut microbiota in the context of type 2 diabetes. Unlike previous studies that address these factors in isolation, this work highlights their dynamic and bidirectional interactions and their collective impact on metabolic regulation. By bridging nutritional biochemistry and microbiome research, the article offers added value in identifying potential synergistic mechanisms underlying disease progression. It also contributes to the field by outlining innovative, nutrition-based and microbiota-targeted strategies that may enhance current approaches to prevention and management of type 2 diabetes.
